Table 2 Mean RSV-attributable burden of respiratory disease among the total population in the United Kingdom
Respiratory Outcome* | Episodes /100,000 population (range) | N | % of events attributable to RSV** | RSV:influenza ratio † |
|---|---|---|---|---|
GP episodes | ||||
Respiratory disease | 1579 (1055–1961) | 927325 | 5.7 | 1.1:1 |
Acute upper respiratory disease | 737 (509–884) | 432716 | 6.0 | 1.2:1 |
Pneumonia and influenza | 75 (34–123) | 43825 | 8.5 | 0.2:1 |
Bronchitis/bronchiolitis | 677 (472–801) | 397665 | 11.5 | 1.6:1 |
COPD | 70 (41–98) | 41214 | 2.4 | 4.1:1 |
Antibiotic prescriptions | 1553 (1111–1820) | 912036 | 5.4 | 1.5:1 |
Hospitalisation (Primary diagnosis) | ||||
Respiratory disease | 83 (61–101) | 48600 | 9.0 | 1.7:1 |
Pneumonia and influenza | 15 (11–19) | 8599 | 9.3 | 1.2:1 |
COPD | 10 (8–13) | 5912 | 3.9 | 0.8:1 |
Cardiorespiratory | 69 (49–81) | 40255 | 4.5 | 1.6:1 |
Bronchitis/bronchiolitis | 47 (34–57) | 27806 | 28.4 | 3.4:1 |
Mortality (Any mention) | ||||
Respiratory disease | 15 (11–21) | 9034 | 5.8 | 0.8:1 |
Pneumonia and influenza | 11 (8–15) | 6603 | 7.0 | 0.7:1 |
COPD | 4 (3–5) | 2561 | 6.9 | 0.9:1 |
Cardiorespiratory | 20 (16–26) | 11600 | 3.9 | 0.8:1 |
Bronchitis/bronchiolitis | 1 (0–1) | 354 | 11.6 | 0.9:1 |